BD to Spin Off Diabetes Care Business
The spinoff is expected to be completed in the first half of calendar year 2022.
Category: Company News
Company News
Latest
Company News
Latest
FDA Warns of Potential for False Positives with Roche Cobas SARS-CoV-2 and Influenza Test
Roche Molecular Systems’ cobas SARS-CoV-2 and Influenza A/B Nucleic Acid Test is for use on the cobas Liat System. The false positive results may be related to two issues observed by Roche.
Company News
Latest
ChromaCode Core HDPCR Technology Demonstrates 20-Plex Capabilities
The HDPCR technology could enable a 5x increase in analytical capacity on existing instruments—which could allow broader global accessibility to precision medicine at an economical cost.
Call for Submissions: Oncomine Clinical Research Grant 2021
Thermo Fisher Scientific is now calling for proposals dedicated to liquid biopsy research. Each proposal may receive an award worth up to $200,000 in reagents and funding.
Read More
Joint Commission President, CEO to Step Down
The Joint Commission Board of Commissioners has begun the search process for the next president and CEO.
Read More
New Plant to Expand Particle Manufacturing Capacity for Covid-19 Testing
Ceres Nanosciences’ facility will be capable of generating a supply of the company’s Nanotrap Magnetic Virus Particles to enable more than 10 million covid-19 tests per month.
Read More
SPT Labtech Acquires BioMicroLab
BioMicroLab designs and manufactures laboratory automation equipment.
Read More
Quidel Opens New Facility to Mass Produce QuickVue Rapid Antigen Tests for Covid-19
The Carlsbad, Calif, Quidel facility aims to reach a run rate of 600 million QuickVue tests per year by the end of 2021.
Read More
Illumina Accelerator Invests in Nine Genomics Startups
The global company creation engine invested in four companies for the second funding cycle of Illumina Accelerator Cambridge, UK and five companies for the twelfth funding cycle of Illumina Accelerator San Francisco Bay Area.
Read More
Veracyte to Acquire Decipher Biosciences
Decipher’s comprehensive portfolio of tests in urologic cancers leverage whole transcriptome analysis and proprietary machine learning algorithms to improve patient decision-making.
Read More
Tecan, UgenTec Partner to Offer Sample-to-Result Solutions for qPCR
The partnership will combine Tecan’s liquid handling and automation expertise with UgenTec’s FastFinder software to provide high-throughput solutions for molecular testing.
Read More
Oncocyte to Acquire Chronix Biomedical
The transaction includes proprietary IP and technology for blood-based immune therapy monitoring and for transplant rejection testing.
Read More
Horiba Acquires MedTest Dx and Pointe Scientific to Expand Laboratory Chemistry Offerings
The acquisition will combine the Horiba Medical’s technology with MedTest Dx technology, Clinitox, and Pointe Scientific’s research and development and manufacturing capabilities.
Read More
Visby Medical Speeds Development of a Rapid Flu-Covid PCR Test for At-Home Use
With BARDA funding, Visby will advance a next-generation device to detect flu and/or covid-19 in one hand-held rapid PCR test for use at the point-of-need and eventually in consumers’ homes as an over-the-counter test.
Read More
Meridian Bioscience to Expand Production Capacity for SARS-CoV-2 Test
A $5.5M award from the National Institutes of Health plus an additional grant from JobsOhio will help Meridian expand production of its Revogene test kits in its Quebec City facility and build a new state-of-the-art, two-line production facility near its corporate headquarters in Ohio.
Read More
Verichem Expands Reporting for Calibration Verification Program
Verichem’s two new reporting options for its free Calibration Verification Data Reduction Program provide pass/fail results.
Read More
SPT Labtech, Thermo Fisher Launch Co-Marketing Initiative to Reduce Costs of NGS Library Prep for Research
The initiative promotes the benefit of using Thermo Fisher Scientific’s library prep kits with SPT Labtech’s instruments to help reduce reagent and material requirements for high-throughput genome sequencing.
Read More
PerkinElmer Joins European Alliance for Newborn Screening in Spinal Muscular Atrophy
The alliance aims to make Spinal Muscular Atrophy testing mandatory in European newborn screening programs by 2025.
Read More